Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: Experience at a tertiary care centre in Oman

H. Farhan, A. Albulushi*, A. Taqi, A. Al-Hashim, K. Al-Saidi, K. Al-Rasadi, A. Al-Mazroui, I. Al-Zakwani

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

7 اقتباسات (Scopus)

ملخص

Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy. Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman. Results: The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the pa-tients were female. There were 11 (19%) cases of thyroid dysfunction (TD). Seven (12%) patients were hypothyroid, 3 (5%) had hyperthyroidism and 1 (2%) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05). Conclusion: Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.

اللغة الأصليةEnglish
الصفحات (من إلى)122-126
عدد الصفحات5
دوريةOpen Cardiovascular Medicine Journal
مستوى الصوت7
رقم الإصدار1
المعرِّفات الرقمية للأشياء
حالة النشرPublished - 2013

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2705???

بصمة

أدرس بدقة موضوعات البحث “Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: Experience at a tertiary care centre in Oman'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا